Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study

Daniel R Morales; Jim Slattery; Alexandra Pacurariu; Luis Pinheiro; Patricia McGettigan; Xavier Kurz

doi:10.1007/s40261-019-00755-y

Correction to: Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study

Clin Drug Investig. 2019 Feb;39(2):215. doi: 10.1007/s40261-019-00755-y.

Authors

Daniel R Morales¹, Jim Slattery², Alexandra Pacurariu², Luis Pinheiro², Patricia McGettigan^{2

3}, Xavier Kurz²

Affiliations

¹ Division of Population Health and Genomics, School of Medicine, University of Dundee, Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, UK. d.r.z.morales@dundee.ac.uk.
² Pharmacovigilance and Epidemiology Department, European Medicines Agency, London, UK.
³ William Harvey Research Institute, Queen Mary University of London, London, UK.

Abstract

The article Relative and Absolute Risk of Tendon Rupture with Fluoroquinolone and Concomitant Fluoroquinolone/Corticosteroid Therapy: Population-Based Nested Case-Control Study, written by Morales DR, Slattery J, Pacurariu A, Pinheiro L, McGettigan P, Kurz X, was originally published Online First without open access.

Publication types

Published Erratum